- Home
- VIR vs SEZL Comparison
VIR vs SEZL Comparison
Compare VIR & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- SEZL
- Stock Information
- Founded
- VIR 2016
- SEZL 2016
- Country
- VIR United States
- SEZL United States
- Employees
- VIR N/A
- SEZL N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- SEZL Diversified Financial Services
- Sector
- VIR Health Care
- SEZL Finance
- Exchange
- VIR Nasdaq
- SEZL Nasdaq
- Market Cap
- VIR 1.4B
- SEZL 1.3B
- IPO Year
- VIR 2019
- SEZL N/A
- Fundamental
- Price
- VIR $9.70
- SEZL $236.64
- Analyst Decision
- VIR Buy
- SEZL Strong Buy
- Analyst Count
- VIR 6
- SEZL 2
- Target Price
- VIR $34.83
- SEZL $366.00
- AVG Volume (30 Days)
- VIR 3.8M
- SEZL 122.8K
- Earning Date
- VIR 02-20-2025
- SEZL 02-26-2025
- Dividend Yield
- VIR N/A
- SEZL N/A
- EPS Growth
- VIR N/A
- SEZL 1005.78
- EPS
- VIR N/A
- SEZL 9.51
- Revenue
- VIR $78,618,000.00
- SEZL $221,806,305.00
- Revenue This Year
- VIR N/A
- SEZL $59.52
- Revenue Next Year
- VIR N/A
- SEZL $33.19
- P/E Ratio
- VIR N/A
- SEZL $25.35
- Revenue Growth
- VIR N/A
- SEZL 49.13
- 52 Week Low
- VIR $6.56
- SEZL $37.61
- 52 Week High
- VIR $14.45
- SEZL $477.53
- Technical
- Relative Strength Index (RSI)
- VIR 52.17
- SEZL 42.07
- Support Level
- VIR $10.09
- SEZL $227.49
- Resistance Level
- VIR $11.39
- SEZL $249.88
- Average True Range (ATR)
- VIR 0.71
- SEZL 23.94
- MACD
- VIR -0.11
- SEZL 2.51
- Stochastic Oscillator
- VIR 16.57
- SEZL 17.27
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase.